Prevention of hepatocellular carcinoma (HCC) associated with non-alcoholic steatohepatitis (nash)
Ended Awarded Last action
- Contract number
- 75N91018F00007
- Awardee
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16 Part of University Of Texas System
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $728,679
Award facts
- Opportunity
-
- N01CN5500347 Solicitation number
- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015
- Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
- Contract value 100% obligated
- $728,679.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Houston, TX 77030, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | -$4,762 | |
| Other Administrative Action | $0 | |
| Original award | $733,441 |
About this award
This is a firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract, valued at $728,679.40, is for research to support the "Prevention of Hepatocellular Carcinoma (HCC) Associated with Non-Alcoholic Steatohepatitis (NASH)". The contract is part of the National Cancer Institute's "Preclinical PREVENT Cancer Program" and does not utilize a set-aside. MD Anderson, a comprehensive cancer treatment and research center, has extensive experience conducting preclinical, translational, and clinical cancer research through both prime and subcontracts with federal agencies like the NIH and Department of Defense.
Quick answers
Who was awarded contract 75N91018F00007?
75N91018F00007 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Cancer Institute (National Institutes of Health) on July 20, 2018.
How much is contract 75N91018F00007 worth?
The government has obligated $728,679 on 75N91018F00007.
Is contract 75N91018F00007 an order under another contract?
Yes. 75N91018F00007 is a delivery order under HHSN261201500018I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract 75N91018F00007 competed?
The extent of competition for 75N91018F00007 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award